Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashamalla

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Neuro-Oncology Advances|July 10, 2020
The effect of brain metastasis location on clinical outcomes: A review of the literaturePragnan Kancharla, Alexander Ivanov, Susie Chan, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2003
Hyperfractionated radiotherapy and paclitaxel for locally advanced/unresectable pancreatic cancerH Ashamalla, B Zaki, B Mokhtar, et al.
Journal of Computer Assisted Tomography|September 12, 2015
Dynamic Susceptibility Contrast Perfusion-Weighted Magnetic Resonance Imaging and Diffusion-Weighted Magnetic Resonance Imaging in Differentiating Recurrent Head and Neck Cancer From Postradiation ChangesAhmed Abdel Khalek Abdel Razek, Gada Gaballa, Germin Ashamalla, et al.
Journal of Neurosurgery. Spine|May 16, 2009
Percutaneous tumor curettage and interstitial delivery of samarium-153 coupled with kyphoplasty for treatment of vertebral metastasesErico R Cardoso, Hani Ashamalla, Lijun Weng, et al.
Radiation Oncology Journal|July 19, 2013
Comparison study of intensity modulated arc therapy using single or multiple arcs to intensity modulated radiation therapy for high-risk prostate cancerHani Ashamalla, Ajay Tejwani, Ioannis Parameritis, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 8, 2012
The role of PET/CT in decreasing inter-observer variability in treatment planning and evaluation of response for cervical cancerAjay Tejwani, Amir Lavaf, Kapila Parikh, et al.
Cancer Epidemiology|August 20, 2023
Lung cancer in nonsmokers- A risk factor analysisDenise Albano, Ankit Dhamija, Yunhan Liao, et al.
Clinical and Translational Radiation Oncology|August 17, 2021
Metformin with neoadjuvant chemoradiation to improve pathologic response in rectal cancer: A pilot phase I/II trialC S Wong, W Chu, S Ashamalla, et al.
Radiation Oncology Journal|April 12, 2014
A predictive model to guide management of the overlap region between target volume and organs at risk in prostate cancer volumetric modulated arc therapyMalcolm D Mattes, Jennifer C Lee, Sara Elnaiem, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 28, 2024
Type I or Type II Endometrial Carcinoma? Role of BRCA1 ImmunohistochemistrySara Ahmed Ali Eldegwi, Maha Mohamed Amin, Sylvia Albair Ashamalla, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Neuro-Oncology Advances|July 10, 2020
The effect of brain metastasis location on clinical outcomes: A review of the literaturePragnan Kancharla, Alexander Ivanov, Susie Chan, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2003
Hyperfractionated radiotherapy and paclitaxel for locally advanced/unresectable pancreatic cancerH Ashamalla, B Zaki, B Mokhtar, et al.
Journal of Computer Assisted Tomography|September 12, 2015
Dynamic Susceptibility Contrast Perfusion-Weighted Magnetic Resonance Imaging and Diffusion-Weighted Magnetic Resonance Imaging in Differentiating Recurrent Head and Neck Cancer From Postradiation ChangesAhmed Abdel Khalek Abdel Razek, Gada Gaballa, Germin Ashamalla, et al.
Journal of Neurosurgery. Spine|May 16, 2009
Percutaneous tumor curettage and interstitial delivery of samarium-153 coupled with kyphoplasty for treatment of vertebral metastasesErico R Cardoso, Hani Ashamalla, Lijun Weng, et al.
Radiation Oncology Journal|July 19, 2013
Comparison study of intensity modulated arc therapy using single or multiple arcs to intensity modulated radiation therapy for high-risk prostate cancerHani Ashamalla, Ajay Tejwani, Ioannis Parameritis, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 8, 2012
The role of PET/CT in decreasing inter-observer variability in treatment planning and evaluation of response for cervical cancerAjay Tejwani, Amir Lavaf, Kapila Parikh, et al.
Cancer Epidemiology|August 20, 2023
Lung cancer in nonsmokers- A risk factor analysisDenise Albano, Ankit Dhamija, Yunhan Liao, et al.
Clinical and Translational Radiation Oncology|August 17, 2021
Metformin with neoadjuvant chemoradiation to improve pathologic response in rectal cancer: A pilot phase I/II trialC S Wong, W Chu, S Ashamalla, et al.
Radiation Oncology Journal|April 12, 2014
A predictive model to guide management of the overlap region between target volume and organs at risk in prostate cancer volumetric modulated arc therapyMalcolm D Mattes, Jennifer C Lee, Sara Elnaiem, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 28, 2024
Type I or Type II Endometrial Carcinoma? Role of BRCA1 ImmunohistochemistrySara Ahmed Ali Eldegwi, Maha Mohamed Amin, Sylvia Albair Ashamalla, et al.
Pageof 9